OMEROS CORP Diluted Shares Outstanding (Weighted Average)
OMEROS CORP (OMER) reported Diluted Shares Outstanding (Weighted Average) of 89.63 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-12
- OMEROS CORP weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 89.63M shares, a 52.98% increase year-over-year.
- OMEROS CORP weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 90.12M shares, a 55.22% increase year-over-year.
- OMEROS CORP weighted average number of shares outstanding, diluted for the quarter ending 2025-06-30 was 58.59M shares.
- OMEROS CORP weighted average number of shares outstanding, diluted for the quarter ending 2025-03-31 was 58.06M shares.
- OMEROS CORP weighted average number of shares outstanding, diluted for fiscal 2022 was 62.74M shares, a 0.63% increase from fiscal 2021.
- OMEROS CORP weighted average number of shares outstanding, diluted for fiscal 2021 was 62.34M shares, a 9.04% increase from fiscal 2020.
- OMEROS CORP weighted average number of shares outstanding, diluted for fiscal 2020 was 57.18M shares, a 15.45% increase from fiscal 2019.
- OMEROS CORP weighted average number of shares outstanding, diluted for fiscal 2019 was 49.52M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 89.63M shares 10-Q · filed 2026-08-12 | 89.88M shares 10-Q · filed 2026-08-12 | |||
| 2026-03-31 | 90.12M shares 10-Q · filed 2026-05-13 | ||||
| 2025-06-30 | 58.59M shares 10-Q · filed 2026-08-12 | 58.32M shares 10-Q · filed 2026-08-12 | |||
| 2025-03-31 | 58.06M shares 10-Q · filed 2026-05-13 | ||||
| 2023-06-30 | 62.84M shares 10-Q · filed 2023-08-09 | 62.83M shares 10-Q · filed 2023-08-09 | 62.81M shares derived: average of 3 quarters · filed 2023-08-09 | 62.79M shares derived: average of 4 quarters · filed 2023-08-09 | |
| 2023-03-31 | 62.83M shares 10-Q · filed 2023-05-09 | 62.80M shares derived: average of 2 quarters · filed 2023-05-09 | 62.77M shares derived: average of 3 quarters · filed 2023-05-09 | 62.76M shares derived: average of 4 quarters · filed 2023-08-09 | |
| 2022-12-31 | 62.76M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | 62.75M shares derived: average of 2 quarters · filed 2023-03-13 | 62.74M shares derived: average of 3 quarters · filed 2023-08-09 | 62.74M shares 10-K · filed 2023-03-13 | |
| 2022-09-30 | 62.73M shares 10-Q · filed 2022-11-09 | 62.73M shares derived: average of 2 quarters · filed 2023-08-09 | 62.73M shares 10-Q · filed 2022-11-09 | 62.69M shares derived: average of 4 quarters · filed 2023-08-09 | |
| 2022-06-30 | 62.73M shares 10-Q · filed 2023-08-09 | 62.73M shares 10-Q · filed 2023-08-09 | 62.68M shares derived: average of 3 quarters · filed 2023-08-09 | 62.63M shares derived: average of 4 quarters · filed 2023-08-09 | |
| 2022-03-31 | 62.72M shares 10-Q · filed 2023-05-09 | 62.65M shares derived: average of 2 quarters · filed 2023-05-09 | 62.60M shares derived: average of 3 quarters · filed 2023-05-09 | 62.55M shares derived: average of 4 quarters · filed 2023-05-09 | |
| 2021-12-31 | 62.57M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | 62.54M shares derived: average of 2 quarters · filed 2023-03-13 | 62.49M shares derived: average of 3 quarters · filed 2023-03-13 | 62.34M shares 10-K · filed 2023-03-13 | |
| 2021-09-30 | 62.51M shares 10-Q · filed 2022-11-09 | 62.44M shares derived: average of 2 quarters · filed 2022-11-09 | 62.27M shares 10-Q · filed 2022-11-09 | 62.12M shares derived: average of 4 quarters · filed 2023-03-13 | |
| 2021-06-30 | 62.37M shares 10-Q · filed 2022-08-09 | 62.15M shares 10-Q · filed 2022-08-09 | 62.17M shares 10-Q · filed 2021-08-09 | 61.99M shares derived: average of 3 quarters · filed 2023-03-13 | 61.05M shares derived: average of 4 quarters · filed 2023-03-13 |
| 2021-03-31 | 61.93M shares 10-Q · filed 2022-05-10 | 61.79M shares derived: average of 2 quarters · filed 2023-03-13 | 60.61M shares derived: average of 3 quarters · filed 2023-03-13 | 59.08M shares derived: average of 4 quarters · filed 2023-03-13 | |
| 2020-12-31 | 61.66M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | 59.95M shares derived: average of 2 quarters · filed 2023-03-13 | 58.14M shares derived: average of 3 quarters · filed 2023-03-13 | 57.18M shares 10-K · filed 2023-03-13 | |
| 2020-09-30 | 58.23M shares 10-Q · filed 2021-11-09 | 56.37M shares derived: average of 2 quarters · filed 2021-11-09 | 55.68M shares 10-Q · filed 2021-11-09 | ||
| 2020-06-30 | 54.51M shares 10-Q · filed 2021-08-09 | 54.41M shares 10-Q · filed 2021-08-09 | |||
| 2019-12-31 | 49.52M shares 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |